Phase 2 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For healthy adults (Part A):
- You are between 18 and 55 years old
- You have a body mass index (BMI) — a measure of body weight relative to height — between 18 and 32
- A doctor has reviewed you and considers you to be in good health
- Your recent blood test results are within a healthy range
For Japanese participants in the healthy adult group only:
- You were born in Japan, both of your biological parents and all four biological grandparents are ethnically Japanese and were born in Japan
- You have maintained a Japanese lifestyle and diet since leaving Japan
- You have been living outside of Japan for fewer than 10 years
For adults with a specific liver condition called MASLD (Parts B and C):
- You are between 18 and 65 years old (Part B) or 18 and 75 years old (Part C)
- If you are of East Asian background (e.g. Chinese, Japanese, South Korean, Taiwanese), your BMI is between 23 and 40; for all other backgrounds, your BMI is between 27 and 40
- A special type of liver scan (MRI) shows that at least 8.5% of your liver is made up of fat
Who may not be able to join:
For healthy adults (Part A):
- You have a significant history of heart, lung, liver, kidney, digestive, hormonal, blood, mental health, nerve, or skin conditions that could affect the study
- You have been in hospital for any reason within the past 30 days
- Your kidney filtering function falls below a certain level (confirm with trial site)
- Your blood test results show that certain liver-related values — ALT, AST, or bilirubin — are above the normal range
- You currently smoke or use e-cigarettes, or you stopped smoking within the last 3 months
- You have a history of alcohol or drug misuse, in the opinion of the study doctor
- You have tested positive for Hepatitis C antibodies and also have an active Hepatitis C virus infection
For adults with MASLD (Parts B and C):
- You have another known long-term liver disease
- You are unable to have an MRI scan for any reason (e.g. a pacemaker or metal implants — confirm with trial site)
- You have a history of Type 1 diabetes
- Your body weight has changed by more than 4% (either gained or lost) in the 3 months before or during the screening period
- You have HIV, an active or ongoing Hepatitis B infection, or an active or ongoing Hepatitis C infection
- You have had weight-loss (bariatric) surgery within the past 5 years (Part B) or 3 years (Part C), or you are planning to have it during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Treatment-Emergent Adverse Events (TEAEs); Severity of TEAEs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.